BIOMAT Database Logo BIOMAT Database Logo

Synaptotagmin: a Lambert-Eaton myasthenic syndrome antigen that associates with presynaptic calcium channels. 1993

N Martin-Moutot, and O el Far, and C Leveque, and P David, and B Marqueze, and B Lang, and J Newsom-Davis, and T Hoshino, and M Takahashi, and M J Seagar
INSERM U374, Faculté de Médecine Secteur Nord, Marseille, France.

Plasma from patients with Lambert-Eaton myasthenic syndrome (LEMS), an autoimmune disease of neuromuscular transmission, contains antibodies that immunoprecipitate 125I-omega-conotoxin GVIA labeled-calcium channels solubilized from rat brain. These antibodies label a 58-kDa protein in Western blots of partially purified 125I-omega-conotoxin receptor preparations. Monoclonal antibody 1D12, produced by immunizing mice with synaptic membranes, has similar properties as these LEMS IgG. 1D12 antigen was purified by immunoaffinity chromatography and shown to bind LEMS IgG. The antigen was identified by immunoscreening a rat brain cDNA library with mAb 1D12 and found to have strong homology to the synaptic vesicle protein synaptotagmin. These antibodies immunoprecipitate calcium channels by binding to synpatotagmin, an associated protein. We suggest that the interaction between synaptotagmin and omega-conotoxin sensitive calcium channels plays a role in docking synaptic vesicles at the plasma membrane prior to rapid neurotransmitter release. Autoantibody binding to a synaptotagmin-calcium channel complex may be involved in the etiology of LEMS.

UI MeSH Term Description Entries
D008297 Male Males
D008562 Membrane Glycoproteins Glycoproteins found on the membrane or surface of cells. Cell Surface Glycoproteins,Surface Glycoproteins,Cell Surface Glycoprotein,Membrane Glycoprotein,Surface Glycoprotein,Glycoprotein, Cell Surface,Glycoprotein, Membrane,Glycoprotein, Surface,Glycoproteins, Cell Surface,Glycoproteins, Membrane,Glycoproteins, Surface,Surface Glycoprotein, Cell,Surface Glycoproteins, Cell
D009419 Nerve Tissue Proteins Proteins, Nerve Tissue,Tissue Proteins, Nerve
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D011233 Precipitin Tests Serologic tests in which a positive reaction manifested by visible CHEMICAL PRECIPITATION occurs when a soluble ANTIGEN reacts with its precipitins, i.e., ANTIBODIES that can form a precipitate. Precipitin Test,Test, Precipitin,Tests, Precipitin
D011955 Receptors, Drug Proteins that bind specific drugs with high affinity and trigger intracellular changes influencing the behavior of cells. Drug receptors are generally thought to be receptors for some endogenous substance not otherwise specified. Drug Receptors,Drug Receptor,Receptor, Drug
D002135 Calcium-Binding Proteins Proteins to which calcium ions are bound. They can act as transport proteins, regulator proteins, or activator proteins. They typically contain EF HAND MOTIFS. Calcium Binding Protein,Calcium-Binding Protein,Calcium Binding Proteins,Binding Protein, Calcium,Binding Proteins, Calcium,Protein, Calcium Binding,Protein, Calcium-Binding
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal

Related Publications

N Martin-Moutot, and O el Far, and C Leveque, and P David, and B Marqueze, and B Lang, and J Newsom-Davis, and T Hoshino, and M Takahashi, and M J Seagar
Antibodies to calcium channel and synaptotagmin in Lambert-Eaton myasthenic syndrome.
April 2000, The American journal of the medical sciences,
N Martin-Moutot, and O el Far, and C Leveque, and P David, and B Marqueze, and B Lang, and J Newsom-Davis, and T Hoshino, and M Takahashi, and M J Seagar
Interference with calcium channels by Lambert Eaton myasthenic syndrome antibody.
January 1987, Annals of the New York Academy of Sciences,
N Martin-Moutot, and O el Far, and C Leveque, and P David, and B Marqueze, and B Lang, and J Newsom-Davis, and T Hoshino, and M Takahashi, and M J Seagar
Antibodies against calcium channels in the Lambert-Eaton myasthenic syndrome.
January 1989, Annals of the New York Academy of Sciences,
N Martin-Moutot, and O el Far, and C Leveque, and P David, and B Marqueze, and B Lang, and J Newsom-Davis, and T Hoshino, and M Takahashi, and M J Seagar
Presynaptic Disorders: Lambert-Eaton Myasthenic Syndrome and Botulism.
August 2015, Seminars in neurology,
N Martin-Moutot, and O el Far, and C Leveque, and P David, and B Marqueze, and B Lang, and J Newsom-Davis, and T Hoshino, and M Takahashi, and M J Seagar
Antibodies to recombinant synaptotagmin and calcium channel subtypes in Lambert-Eaton myasthenic syndrome.
November 1995, Journal of the neurological sciences,
N Martin-Moutot, and O el Far, and C Leveque, and P David, and B Marqueze, and B Lang, and J Newsom-Davis, and T Hoshino, and M Takahashi, and M J Seagar
Neuronal calcium channels as target for Lambert-Eaton myasthenic syndrome autoantibodies.
June 1993, Annals of the New York Academy of Sciences,
N Martin-Moutot, and O el Far, and C Leveque, and P David, and B Marqueze, and B Lang, and J Newsom-Davis, and T Hoshino, and M Takahashi, and M J Seagar
[Lambert-Eaton myasthenic syndrome].
January 1994, Ryoikibetsu shokogun shirizu,
N Martin-Moutot, and O el Far, and C Leveque, and P David, and B Marqueze, and B Lang, and J Newsom-Davis, and T Hoshino, and M Takahashi, and M J Seagar
Lambert-Eaton myasthenic syndrome.
September 1999, Postgraduate medical journal,
N Martin-Moutot, and O el Far, and C Leveque, and P David, and B Marqueze, and B Lang, and J Newsom-Davis, and T Hoshino, and M Takahashi, and M J Seagar
[Eaton-Lambert myasthenic syndrome].
January 2010, Biomedica : revista del Instituto Nacional de Salud,
N Martin-Moutot, and O el Far, and C Leveque, and P David, and B Marqueze, and B Lang, and J Newsom-Davis, and T Hoshino, and M Takahashi, and M J Seagar
Lambert-Eaton myasthenic syndrome.
January 2009, BMJ case reports,
Copied contents to your clipboard!